MCLA-128

· Merus B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MCLA-128, covering 2024-03-07 to 2024-03-07. Get the full timeline:

Most recent: Clinical Trial Update: MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer. [Phase 2]

See pricing